Analysis of causes for liver function deterioration in patients with HIV/HCV co-infection

Hepatobiliary and Pancreatic Diseases International

Volumn 3, Issue 4, 2004, Pages 538-542

  Zhang, Yong Hong ^a   Chen, Xin Yue ^a   Jiang, Yan ^b   Xiao, Yao ^b   Liu, Zhen ^b   Long, Xiao Shan ^b   Wu, Hao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

CD4+T cell; HCV RNA; Hepatitis C virus; HIV virus

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DETERIORATION; DISEASE COURSE; DISEASE DURATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE RESPONSE; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER FUNCTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NONHUMAN; PATHOLOGY; QUALITATIVE ANALYSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SUPERINFECTION;

ADULT; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMANS; IMMUNE SYSTEM; LIVER; MALE; MIDDLE AGED; RNA, MESSENGER; RNA, VIRAL; TIME FACTORS;

EID: 9444267629     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Soriano V, Garcia-Samaniego J, Valencia E, Rodriguez-Rosado R, Munoz F, Gonzalez-Lahoz J. Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users. Eur J Epidemiol 1999;15:1-4.
2. Soriano V, Kirk O, Antunes F. The influence of hepatitis C on the prognosis of HIV: the EuroSIDA Study. In: X IIIth international AIDS Conference. Durban, July 2000 [Abstract ThOrB655].
3. Hagan H, Thiede H, Weiss N, Hopkins S, Duchin J, Alexander E. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001;91:42-46.
4. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001;32:492-497.
5. Justic AC, Chang CH, Fusco. Extrapolating long-term HIV/AIDS survival in the post-HAART era [abstract 1158]. In: Program and abstracts of the 39th Annual International Conference on antimicrobial agents and chemotherapy. American Society for Microbiology, 1999.
6. den Brinker M, Wit FW, Wertheim-van Dillen PM, Jurriaans S, Weel J, van Leeuwen R, et al. Hepatitis B and C virus coinfection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection. AIDS 2000;14:2895-2902.
7. The Program of Prevention and Treatment of Viral Hepatitis. Chin J Contagious Dis 2001;19:56-62.
8. Sherman K, Roustrer S, Chung R. Hepatitis C: prevalence in HIV-infected patients across sectional analysis of the US ACTG. Antiviral Ther 2000;5:64-65.
9. Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001;91:42-46.
10. Luo RD. The Lecture on contagious diseases. 1st ed. Beijing: The People's Health Publishing House; 2002:114-122.
11. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 1993;6:602-610.
12. Puoti M, Bonacini M, Spinetti A, Putzolu V, Govindarajan S, Zaltron S, et al. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis 2001;183:134-137.
13. Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 2001;33:562-569.
14. Ragni MV, Belle SH. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J Infect Dis 2001;183:1112-1115.
15. Soto B, Sanchez-Quijano A, Rodrigo L, del Olmo JA, Garcia-Bengoechea M, Hernandez-Quero J, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997;26:1-5.
16. Teague W, Hepworth J, Krug G. Support for patients with hepatitis C: an exploratory qualitative study of medical specialists' perceptions. Aust N. Z. J. Public Health 1999;23:201-203.
17. Wang KX, Li CP, Wang J. The examination of PBMC Mil-2R and T cell subgroup on the patients with Hepatitis C. J Jishou University (the edition of natural sciences) 2001;22:79-82.
18. Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2. 1 binding Moti. J Clin Invest 1995;95:521-530.
19. Muller HM, Pfaff E, Goeser T, Kallinowski B, Solbach C, Theilmann L. Peripheral leukocytes serve as a possible extrahelatic site for hepatitis C virus replication. J Gen Virol 1993;74: 669-676.
20. Wang J, Zhang XB, Xu LF. The effect of HCV infection on cellular immune function. J Anhui Med University 1999;34: 103-105.
21. Rockstroh JK, Spengler U, Sudhop T, Ewig S, Theisen A, Hammerstein U, et al. Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. Am J Gastroenterol 1996;91:2563-2573
22. Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ. Increasing hepatitis C virus RNA levels in hemophiliacs with antibody to hepatitis C virus (HCV): relationship to human immunodeficiency virus (HIV) infection and liver disease. Blood 1994; 84:1020-1023.
23. Soriano V, Garc Samaniego J, Bravo R, Gonzalez J, Castro A, Castilla J, et al. Interferon alpha for treatment of chronic hepatitis C in patients infected with HIV. Hepatitis-HIV Spanish Study Group. Clin Infect Dis 1996;23:585-591.
24. Mauss S, Klinker H, Ulmer A, Willers R, Weissbrich B, Albrecht H. Response to treatment of chronic hepatitis C with interferon alpha in patients infected with HIV-1 is associated with higher CD4 + cell count. Infection 1998;26:16-19.
25. Rockstroh J, Schulz C, Mauss S, Klausen G, Voigt E, Golz J. Pegylated interferon-alpha and ribavirin therapy for hepatitis C in HIV-coinfected patients: 24 weeks results. In: XIVth World AIDS Conference. Barcelona, Spain, 7-2 July 2002 [Abstract WePeB6025].
26. Soriano V, Puoti M, Sulkowski M, Mauss S, Cacoub P, Cargnel A, et al. Care of patients with hepatitis C and HIV coinfection. AIDS 2004;18:1-12